- FDA approval received for prefilled syringe format of Purified Cortrophin Gel.
- The drug is indicated for acute exacerbations of various conditions including rheumatoid arthritis and psoriatic arthritis.
- Caution is advised for patients with comorbid conditions and during pregnancy.
- Contraindications include systemic fungal infections, ocular herpes simplex, congestive heart failure, recent surgery, and primary adrenocortical insufficiency.
- Potential adverse effects may include fluid retention, muscle weakness, osteoporosis, hypertension, mood alterations, and immunosuppression.
Conexiant
chevron_right
Rheumatology
chevron_right
FDA Approves Prefilled Syringe for Cortrophin Gel
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Advertisement
Recommendations
Advertisement